Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 20-65 years~* Serum triglyceride \>150mg/dl AND/OR total cholesterol \>= 240mg/dl~Exclusion Criteria:~* Serum triglyceride \> 500 mg/dl~* Serum LDL-cholesterol at level which need drug treatment according to the patient risk categories (NCEP-ATP III)~* Diabetes mellitus~* Hypo. or hyperthyroidism~* Any systemic illnesses e.g. liver cirrhosis, acute or chronic renal failure, heart failure~* Use of drugs: OCPs, lipid lowering agents, thiazides~* Pregnancy~* Alcoholism~* History of allergic reaction to Somagh

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Rhus (Type: EXPERIMENTAL): 500 mg of Rhus Coriaria L. (Rhus) powder in capsule: 1 capsule twice daily for 6 weeks
- Placebo (Type: PLACEBO_COMPARATOR): Placebo capsule: 1 capsule twice daily for 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).